Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Enanta Pharmaceuticals Inc. buy Rodman & Renshaw

Enanta Pharmaceuticals Inc.
Start price
€10.60
26.03.26 / 50%
Target price
€17.30
26.03.27
Performance (%)
6.60%
Price
€11.30
14.08.26
Summary
This prediction is currently active. With a performance of 6.60%, the BUY prediction by Rodman___Renshaw for Enanta Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 26.03.27. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Enanta Pharmaceuticals Inc. 0.893% 0.893%
iShares Core DAX® 0.437% 5.640%
iShares Nasdaq 100 1.057% 0.282%
iShares Nikkei 225® 1.769% 0.406%
iShares S&P 500 0.368% 1.920%

Comments by Rodman___Renshaw for this prediction

In the thread Enanta Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 6.60%
Target price 17.302
Change
Ends at 26.03.27

Enanta Pharmaceuticals (ENTA) is now covered by Rodman & Renshaw. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat

Rodman & Renshaw 
0
Report Share
26.03.26